Tag Archives: Bad Faith

Drug Regulation

Breaking News: Natco Admits to Bad Faith and BMS attempts Patent Linkage!


In a startling revelation, Natco admitted (albeit indirectly) that it had lied in its response to BMS’s quia timet law suit, wherein BMS approached the Delhi High Court in 2009, apprehending imminent infringement of its patent covering Dasatinib, an anti cancer drug.  In an earlier post, I noted that Natco may have committed a fatal legal blunder by stating on oath before the Delhi High court that: “It is denied that the Defendants intend to launch a generic version of…


Read More »